These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24289528)

  • 21. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
    Kakaire O; Tumwesigye NM; Byamugisha JK; Gemzell-Danielsson K
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):220-6. PubMed ID: 26895345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Wildemeersch D; Goldstuck ND; Jackers G
    Gynecol Endocrinol; 2017 Mar; 33(3):223-226. PubMed ID: 28084114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system.
    Gemzell-Danielsson K; Inki P; Heikinheimo O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.
    Nanda G; Rademacher K; Solomon M; Mercer S; Wawire J; Ngahu R
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):303-308. PubMed ID: 30198796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female sexual function in women using LARC methods.
    Trigo ACM; Maron CC; Pinheiro MSA; da Silva SBL; Brito MB
    Gynecol Endocrinol; 2022 Jan; 38(1):68-72. PubMed ID: 34672861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L; Brache V; Ali M; Habib N;
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of progestin-only long-acting contraception on metabolic markers in obese women.
    Bender NM; Segall-Gutierrez P; Najera SO; Stanczyk FZ; Montoro M; Mishell DR
    Contraception; 2013 Sep; 88(3):418-25. PubMed ID: 23410714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
    Moray KV; Chaurasia H; Sachin O; Joshi B
    Reprod Health; 2021 Jan; 18(1):4. PubMed ID: 33407632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of 52-mg Levonorgestrel-Releasing Intrauterine System in Adolescents and Young Adult Women: 3-Year Follow-Up.
    Oliveira ECF; Baêta T; Cotta RCF; Rocha ALL
    J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):45-50. PubMed ID: 36089114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
    Radesic B; Sharma A
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.
    Ramhendar T; Byrne P
    Contraception; 2012 Sep; 86(3):288-9. PubMed ID: 22305914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.